Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2017-10-16

Clinical Trial Update: Reduced-Intensity Conditioning Followed By Donor Peripheral Blood Stem Cell Transplant in Treating Patients With Multiple Myeloma [Phase 1, Phase 2]

View source ↗

Summary

This study updates Phase 1/2 trial results for reduced-intensity conditioning followed by donor peripheral blood stem cell transplantation in patients with mult…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Fred Hutchinson Cancer Center | Conditions: Refractory Multiple Myeloma | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2017-10-16